![](https://webarchive.library.unt.edu/eot2008/20090511011930im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090511011930im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090511011930im_/http://www.cancer.gov/images/spacer.gif)
| Sustancia en estudio para el tratamiento de algunos tipos de cáncer. Bloquea las enzimas (cinasas Aurora) que participan en la división celular y podría destruir las células cancerosas. El inhibidor de la cinasa Aurora AT9283 es un tipo de inhibidor de la proteína cinasa de serina/treonina. También se llama AT9283. |
![](https://webarchive.library.unt.edu/eot2008/20090511011930im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090511011930im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090511011930im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20090511011930im_/http://www.cancer.gov/images/spacer.gif) |